Cyclooxygenase-2 (COX-2) plays an important role in the inflammatory response induced by physiologic and stress stimuli. Exposure to diesel exhaust particulate matter (DEP) has been shown to induce pulmonary inflammation and exacerbate asthma and chronic obstructive pulmonary disease. DEP is a potent inducer of inflammatory reponses in human airway epithelial cells. The mechanism through which DEP inhalation induces inflammatory mediator expression is not understood. In this report, we demonstrate that DEP can induce the expression of COX-2 gene in a human bronchial epithelial cell line (BEAS-2B) at both transcriptional and protein levels. The induction of COX-2 gene expression involves chromatin modification, in particular acetylation and deacetylation of histones. We show that exposure to DEP increases the acetylation of histone H4 associated with the COX-2 promoter and causes degradation of histone deacetylase 1 (HDAC1). Further, we establish that HDAC1 plays a pivotal role in mediating the transcriptional activation of the COX-2 gene in BEAS-2B cells exposed to DEP, supported by evidence that the down-regulation of HDAC1 using siRNA leads to activation of COX-2 gene expression, whereas overexpression of HDAC1 results in its repression. Finally, DEP exposure induced recruitment of histone acetyltransferase (HAT) p300 to the promoter of the COX-2 gene, suggesting that acetylation is also important in regulating its expression in response to DEP exposure. These results show for the first time acetylation via selective degradation of HDAC1, and that recruitment of HAT plays an important role in DEP-induced expression of the COX-2 gene.
inflammatory diseases including rheumatoid arthritis, osteoarthritis, ulcerative colitis, and atherosclerosis (1) .
Diesel exhaust particles (DEP) are ubiquitous ambient air pollutants, accounting for up to 90% of urban ultrafine particulate mass (4) . Exposure to DEP has been associated with numerous adverse respiratory health outcomes including increased susceptibility to respiratory infections, increased risk of cancer, and exacerbation of asthma and chronic obstructive pulmonary disease (5) . Inflammatory responses are thought to play a pivotal role in the pathophysiology of DEP inhalation (6, 7) . In vitro and in vivo studies have shown that DEP can stimulate human airway epithelial cells to produce inflammatory cytokines and mediators such as IL-6, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), and intercellular adhesion molecule-1 (ICAM-1) (8) . Increased expression of these genes is believed to be largely regulated at a transcriptional level. DEP was also found to potentiate LPS-stimulated COX-2 expression in human monocytes (9) and murine lung cells (10) . It should be noted that V 2 O 5 , one of trace metals in DEP, can strongly induce expression of COX-2 expression in the distal airway epithelium (11) . However, little is known about the effect of DEP on the expression of COX-2 in the human bronchial epithelium, a primary target of inhaled DEP. Moreover, no study has been reported on the molecular mechanism underlying DEP-induced expression of the COX-2 gene.
Reversible chromatin modifications, including acetylation, phosphorylation, and methylation, play a critical role in the transcriptional regulation of gene expression (12) . Among those modifications, acetylation and deacetylation of histone lysine residue has been best characterized (13) . DNA is tightly packaged into chromatin by histone proteins, which prevents access of transcriptional activators. Acetylation of histones results in unwinding of DNA wrapped around the histone core, allowing transcription activators access to DNA, thereby leading to gene expression (12) . Many transcription co-activators have histone acetyltransferase activity (HAT), for example, p300/CBP (14) , which can be recruited by activated transcription activators such as NF-B and activator protein-1 (AP-1) (15) . NF-B is an important transcription factor mediating TNF-␣-induced activation of expression of COX-2 gene (16) . On the other hand, acetylation can be reversed by histone deacetylase (HDAC), which increases winding of DNA around a histone core, resulting in repression of gene expression (17) .
In mammalian cells, there are at least 10 HDACs, which can be divided into two categories based on homology to their yeast counterparts (18) . Class I HDACs are comprised of the proteins HDAC1, -2, -3, -8, and -11, which are homologous to yeast protein RPD3. They are universally expressed and localized in the nucleus (19) . Class II is composed of HDAC4, -5, -7, -9, and -10, which are related to yeast HAD1. They are expressed in a tissue-specific manner and shuttle between cytoplasm and nucleus in response to signaling (20) . Both classes of HDACs exist in a large repressor complex such as mSin3 and NruD (21) , which can be brought to the promoters by interaction with transcription factors (22) . HDACs can also directly interact with transcription factors, for example YY1 (23) . Recently, HDAC1 and HDAC2 have been demonstrated to interact with NF-B, converting it from an activator to a repressor (24) .
In this study, we show that chromatin acetylation plays a pivotal role in DEP-induced expression of COX-2 in the human bronchial epithelial cell line BEAS-2B. We found that COX-2 expression is up-regulated at both mRNA and protein levels in response to DEP treatment. Concurrently, acetylation of histone H4 in the COX-2 promoter is also increased and is accompanied by increased binding of p300 and RNA polymerase II but not p65 to the promoter. This is mediated through the selective degradation of HDAC1. These data suggest that histone acetylation is an important feature in DEP-induced expression of COX-2.
MATERIALS AND METHODS

Reagents and Plasmid
Keratinocyte basal medium (KBM) and growth media (KGM) were obtained from Cambrex (East Rutherford, NJ). Rabbit polyclonal antibody against HDAC1, HDAC2, HDAC3, p65, and p300 were purchased from Santa Cruz (Santa Cruz, CA). Mouse monoclonal antibody against COX-2 was obtained from Cayman (Ann Arbor, MI). HDAC and HAT activity assay kits were purchased from Upstate (Lake Placid, NY). Antibody against ␣-actin and Trichostatin A were purchased from Sigma (St. Louis, MO). The plasmids pKD-HDAC1-v4 encoding siRNA against HDAC1 and negative control vector pKD-NegCon-v1 were purchased from Upstate.
Preparation of DEP
DEP, designated NIST-DEP, was obtained from the National Institute of Sciences and Technology (NIST) Donaldson Company (Minneapolis, MN). The material was collected from the exhaust of a diesel-powered forklift and hot bag filter system. The diesel particulate material was collected in a 55-gallon drum, and subsequently homogenized in a V-blender for 1 h and stored in a polyethylene bags. The certified analyses of these particles are available at http://patapsco.nist.gov/ srmcatalog/certificates/2975.pdf.
Cell Culture and Treatment
The human bronchial epithelial cell line BEAS-2B was cultured as previously described (25) . In brief, 5 ϫ 10 5 cells were seeded on tissue culture plate coated with human collagen (Sigma) and grown to confluence in KGM (Cambrex). This medium contains full supplements and growth factors. The cells were then passaged two or three times in KGM on ordinary tissue culture plates. Before treatment with NIST-DEP, cells were starved in KBM without supplements for 12-16 h. No significant decrease in cell viability was found after treatment with up to 20 g/cm 2 NIST-DEP for 24 h (data not shown).
Western Blot Analysis
Western blot analysis was performed as previously described (25) with minor modification. Briefly, cells were lysed with lysis buffer containing 50 mM Tris-HCL, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethanesulfonyl fluoride, one tablet of proteinase inhibitor (Roche, Indianapolis, IN), 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS. The lysates were sonicated for 10 s and centrifuged, and supernatants were collected. The protein concentration was determined using Protein Assay Solution (Bio-Rad, Hercules, CA). The lysates were separated by electrophoresis in SDS-PAGE and then transferred to a nitrocellulose membrane (Bio-Rad). Western blots were probed with antibodies described above. The protein bands were detected by enhanced chemiluminescence (Amersham, GE Healthcare, Piscataway, NJ).
HDAC Activity Assay
HDAC activity assays were performed using a colorimetric method according to the manufacturer's instructions (Upstate). Briefly, cells were treated with NIST-DEP at a concentration of 10 g/cm 2 for 4 h. The lysates were collected in RIPA and incubated with 100 M of acetylated substrate in 40 l of assay solution for 60 min at 37 o C. Twenty microliters of Activator Solution was added to the reaction, followed by 10 min of incubation. The quantification of deacetylation activity was determined by reading absorbance at 405 nm.
HAT Activity Assay
HAT activity assay was performed according to manufacturer's instructions. Briefly, total cellular protein was extracted and suspended in 150 l of HAT buffer (50 mM Tris-HCL, pH 8.0, 10% glycerol, 1 mM dithiothreitol, 0.1 mM ethylenediaminetetraacetic acid [EDTA], protease inhibitor). The reaction was set up by adding 2 l of core histones, 5 l of 5ϫ HAT assay buffer, 5 l of [ 3 H]acetyl-coenzyme A, and 13 l of cellular extracts followed by 10 min of incubation at 30 o C. Ten microliters of reaction mixture was spotted onto p81 paper and, after drying, washed three times with 10% trichloroacetic acid for 5 min each followed by the final wash with 95% ethanol. The dried filter was counted in a liquid scintillation counter.
DNA Transfection and Luciferase Assays
Transfections of BEAS-2B cells and luciferase assays were performed as previously described (26) . Cells were seeded at a density of 5 ϫ 10 4 cells per well in 6-well plates and grown to 50-70% confluence. Unless otherwise indicated, 100 ng of reporter plasmid, 100 ng of Renilla luciferase, and 100 ng of each activator plasmid were used. The total amount of DNA per well was kept constant by adding the corresponding amount of expression vector without a cDNA insert. Transfections were performed using FuGENE 6 (Roche) according to the manufacturer's instruction. After 36-48 h of incubation, luciferase activity was determined using a Dual Luciferase assay kit (Promega, Madison, WI). All of the transfection experiments were repeated at least twice in duplicate. Values are expressed as means Ϯ SD.
Transfections of BEAS-2B cells with plasmids encoding siRNA against HDAC1 were carried out using Effectene according to manufacturer's instruction (Qiagen, Valencia, CA).
ChIP Assays
Chromatin immunoprecipitation (ChIP) assays were carried out using the ChIP assay kit from Upstate Biotech. Briefly, cellular proteins were cross-linked with 1% formaldehyde at 37ЊC for 10 min. After being washed with cold PBS twice, cells were scraped in 500 l of PBS and centrifuged at 5,000 rpm. The pellets were then resuspended in 300 l of SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl [pH 8.1], protease inhibitors). The lysate was sonicated three times for 10 s each to shear the DNA into segments between 200 and 1,000 bp in length. After being centrifuged at 14,000 rpm for 10 min, the supernatants were diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1], 167 mM NaCl, protease inhibitors). One milliliter of the diluted lysate was then cleared with 10 g of salmon sperm DNA and 20 l of protein Aagarose beads at 4ЊC for 1 h. After brief centrifugation to pellet the beads, the supernatant was incubated with 2 l of specific antibodies overnight at 4ЊC. The next day, 10 g of salmon sperm DNA and 40 l of protein A-agarose beads were added to the supernatant, and the mixture was incubated for 2 h. The beads were then washed sequentially with low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8], 150 mM NaCl), high-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8], 500 mM NaCl), and LiCl wash buffer (0.25 mM LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl [pH 8.1]) for 5 min each. The beads were then washed two times with Tris-EDTA, and the precipitates were eluted twice with 200 l of elution buffer (1% SDS, 0.1 M NaHCO 3 ). Twenty microliters of 5 M NaCl was added to each eluate, and the mixture was incubated at 65ЊC for 4 h to reverse crosslinking. DNA fragments were then purified with a QIAquick spin column. The anti-IgG antibody was from Santa Cruz, and the anti-acetyl histone H3 and H4 antibody used was from Upstate. The primers for the COX-2 promoter were 5ЈGGCAAAGACTGCGAAGAAGA3Ј and 5ЈGGGTAGGCTTTGCTGTCTGA 3Ј. The PCR product covers DNA sequence from Ϫ307 to ϩ46 and contains NF-B, cyclic AMP response element (CRE), CCAAT-enhancer binding protein (C/EBP), and TATA cis-elements in the promoter region. The PCR reaction was performed at 95ЊC for 2 min followed by 35 cycles of 95 o C for 30 s, 55 o C for 30 s, and 72 o C for 30 s. The PCR products were separated on a 1.4% agarose gel and stained with ethidium bromide.
Real-Time PCR
Relative gene expression in BEAS-2B cells was quantified using realtime quantitative PCR. Total RNA was isolated using a Qiagen kit (Qiagen) and reverse transcribed to generate cDNA using a High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA). Oligonucleotide primer pairs and fluorescent probes for COX-2 and GAPDH were designed using a primer design program (Primer Express; Applied Biosystems) and obtained from Integrated DNA Technologies (Coralville, IA). The HDAC1 primer/probe set was obtained as a Taqman pre-developed assay reagent (concentrated and preoptimized mix of primers and FAM-labeled Taqman probe) from Applied Biosystems. Quantitative fluorogenic amplification of cDNA was performed using the ABI Prism 7500 Sequence Detection System (Applied Biosystems), primers and probes of interest and TaqMan Universal PCR Master Mix (Applied Biosystems). The relative abundance of mRNA levels were determined from standard curves generated from a serially diluted standard pool of cDNA prepared from BEAS-2B cells. The relative abundance of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used to normalize levels of the mRNAs of interest.
RESULTS
DEP Exposure Induces Expression of COX-2 Gene at mRNA and Protein Levels
In a previous in vitro study in human monocytes it was reported that exposure to DEP induced increased expression of COX-2 at the mRNA level without an accompanying elevation in the protein concentration (9) . Because the epithelium of the conducting airways is the first tissue challenged by inhaled DEP, we chose to examine COX-2 expression in response to DEP using the human bronchial epithelial cell line BEAS-2B as a model.
BEAS-2B cells were grown to confluence, and placed in media deprived of growth factors overnight before being treated with NIST-DEP at a concentration of 10 g/cm 2 for 4, 8, and 16 h. The levels of COX-2 mRNA were measured using realtime PCR. As shown in Figure 1A , exposure to DEP increased COX-2 gene expression at a transcriptional level. Compared with unexposed controls, the levels of COX-2 mRNA increased markedly, peaking at 8 h of exposure before diminishing at 16 h. Western Blot analysis showed that levels of COX-2 protein increased following a pattern consistent with that predicted by the mRNA levels over the same time course ( Figure 1B ). In contrast, mRNA and protein levels of the constitutively expressed COX-1 enzyme were not changed by DEP exposure of BEAS cells (data not shown). These data showed that exposure to DEP can increase the expression of COX-2 at both mRNA and protein levels in BEAS-2B cells.
DEP Exposure Induces the Acetylation of Histone H4
Having established that DEP activate expression of COX-2 gene at a transcriptional level, we next examined the role of histone modification in this effect. Since hyperacetylation of histone tails is associated with increased gene expression and histone H3 and H4 are the principal histone targets of HDAC enzymatic activity (27) , we used the ChIP assay to determine whether DEP treatment results in an increase in acetylated histones H3 or H4 in the promoter region of COX-2 in BEAS-2B cells. Cells were treated with NIST-DEP (10 g/cm 2 ) for 4 h and chromatin was then immunoprecipitated with an antibody raised against acetyl H3 and H4. The DNA in the COX-2 promoter (from Ϫ307 to ϩ46) was amplified by PCR using specific primers and the amplicon was detected by electrophoresis. As shown in Figure 2 , cells stimulated with NIST-DEP for 4 h exhibited a stronger COX-2 band than cells without NIST-DEP treatment, indicating that exposure to DEP increased the acetylation in histone H4 associated with the COX-2 promoter. In contrast, there was no significant change in acetyl histone H3 in response to NIST-DEP treatment. An increase in acetyl histone H4 without a concomitant change in acetyl histone H3 has been shown to occur in the insulinoma cell line MIN6 stimulated with glucose, and in A549 cells treated with TNF-␣ (28, 29) .
DEP Exposure Inhibits HDAC Activity
The acetylation status of core histones is dynamically controlled by the opposing actions of two classes of enzymes, HAT and HDAC (12, 13) . HATs acetylate lysines in the N-terminal tail of histones, whereas HDACs catalyze the removal of these acetyl groups. Under resting conditions, the activities of these enzymes are in equilibrium. A disruption of this balance can result in hyperacetylation or hypoacetylation, leading to activation or repression of gene expression (12, 13) . To investigate whether the DEP-induced change in H4 acetylation status is due to alterations in HDAC activity, we assayed the enzymatic activity of HDAC using a colorimetric method based on the spectrophotometric detection of the chromophore p-nitroanilide. As shown in Figure 3A , HDAC activity in BEAS-2B cells was dose-dependently inhibited in response to treatment with NIST-DEP at a concentration as low as 5 g/cm 2 . As a negative control, H 2 O did not induce HDAC activity, while TSA, a general HDAC inhibitor, potently inhibited HDAC activity, as expected. These results suggested that DEP exposure inhibits HDAC activity in the BEAS-2B cells.
We also investigated the possibility that the increase in acetylated H4 in DEP-exposed BEAS-2B cells is partly the result of an increase in HAT activity in the BEAS-2B cells. HAT activity in BEAS-2B cell lysates was assayed by measuring the incorporation of [ 3 H]Acetyl-CoA into a core histone substrate. As shown in Figure 3B , BEAS-2B cells had detectable levels of HAT activity. However, exposure to NIST-DEP for 4 h did not cause a significant alteration in HAT activity (Figure 3 ). These data demonstrated that NIST-DEP treatment does not directly increase HAT activity, implying that the increase in H4 acetylation following NIST DEP exposure is primarily due to an inhibition of HDAC in BEAS-2B cells. 
DEP Exposure Down-Regulates the Expression of HDAC1 through a Proteasomal Pathway
The observation of decreased HDAC activity suggested diminished levels of HDAC protein in DEP-treated BEAS-2B cells. HDAC1, -2, and -3 are present in lung tissue, and their expression is altered in response to inflammatory states (30) . We therefore measured levels of HDAC1, -2, and -3 after DEP treatment. Constitutive expression of HDAC1, -2, and -3 protein was detectable in cell lysates prepared from untreated BEAS-2B cells ( Figure  4A ). NIST-DEP exposure induced a marked time-dependent reduction in the level of HDAC1 in these cells, which was evident by 1 h and progressed by 4 h of exposure. No effect of NIST-DEP exposure was evident on the expression of HDAC2 and -3 ( Figure 4A ).
PCR analysis showed that DEP exposure did not result in a change in mRNA levels of HDAC1 in BEAS-2B cells, suggesting that the DEP-induced loss of HDAC protein is post-transcriptionally regulated ( Figure 4B ). Proteasomal and lysosomal Lysates were collected in RIPA buffer and 30 g of proteins were loaded for electrophoresis. The protein levels of HDAC1, HDAC2, and HDAC3 were detected using antibodies against HDAC1, HDAC2, and HDAC3. Anti-␣-actin antibody recognizing total ␣-actin was used to demonstrate equal loading. (B ) Cells were treated for 4 h and total RNA was isolated. Levels of COX-2 mRNA were quantified by real-time PCR. Expression levels of COX-2 gene were normalized relative to the levels of GAPDH. (C ) Cells were treated for MG132 at a concentration of 10 nM and Chloroquine at 10 M for half hours and then subject to DEP (10 g/cm 2 ) for 4 h. Lysates were collected in RIPA buffer and 30 g of proteins were loaded for electrophoresis. The detection of protein levels of HDAC1 and loading controls was performed as described in A.
protein degradation are two major post-transcriptional mechanisms that regulate intracellular levels of specific proteins. To evaluate the role of these pathways in the DEP-induced loss of HDAC1, BEAS-2B cells were treated with MG132, an inhibitor of the proteasome pathway, or with chloroquine, an inhibitor of the lysosomal pathway, for 30 min before treatment with 10 g/cm 2 of NIST-DEP for 4 h. As shown in Figure 4C , MG132 significantly blocked NIST-DEP-induced HDAC1 disappearance, whereas chloroquine did not have a discernible effect. These results indicated that exposure to DEP induces degradation of HDAC1 via a mechanism that is dependent on proteasomal activity in BEAS-2B cells.
Loss of HDAC1 Mediates COX-2 Expression in Response to DEP Exposure
A series of experiments was undertaken to further characterize the link between DEP-induced degradation of HDAC1 and the expression of COX-2 in human bronchial epithelial cells. First, we tested the effect of the histone deacetylase activity inhibitor Trichostatin A (TSA) on COX-2 mRNA levels in BEAS-2B cells. As shown in Figure 5 , treatment with TSA increased expression of the COX-2 gene in a dose-and time-dependent manner, demonstrating that down-regulation of HDAC activity can lead to the transcriptional activation of COX-2 gene expression in BEAS-2B cells.
Next, we used siRNA to knock down expression of HDAC1 and measured the effect on the expression of the COX-2 gene. Transfection of the plasmid encoding siRNA against HDAC1 reduced the expression of HDAC1 by 40% ( Figure 6A ). As a negative control, transfection of a plasmid encoding a scrambled RNA had no effect on HDAC1 RNA levels. In the cells in which HDAC1 expression was diminished, expression of the COX-2 gene increased 2-fold relative to the scrambled control. These data demonstrate that knock-down of HDAC1 can cause transcriptional activation of COX-2 gene expression.
To further examine the functional relevance of HDAC1 expression levels in the activation of the COX-2 gene, we examined the effect of overexpression of HDAC1 on COX-2 promoter activity in DEP-exposed BEAS-2B cells. As shown in the Figure  6B , DEP-NIST increased COX-2 promoter activity in a dosedependent manner, suggesting that DEP can stimulate the COX-2 expression in a manner consistent with the PCR data presented in Figure 1 . Overexpression of HDAC1 effectively blocked the expression of COX-2 in induced by a wide range of DEP concentrations ( Figure 6B ).
Together these data show that the level of HDAC1 expression is a functional determinant of COX-2 expression in BEAS-2B cells under baseline conditions as well as in response to DEP exposure.
DEP Exposure Increases p300 Binding to the COX-2 Promoter
While the results shown in Figure 3 ruled out an increase in HAT activity, they did not exclude the possibility that an alteration in the intracellular distribution of HAT activity contributes to DEP-induced COX-2 expression. HAT p300 has been shown to be recruited by NF-B to the COX-2 promoter in response to TNF-␣ (16). We therefore investigated the involvement of p300 in DEP-induced COX-2 expression using the ChIP assay.
Relative to unexposed controls, exposure to DEP induced a clear increase in levels of p300 bound to the COX-2 promoter in BEAS-2B cells (Figure 7 ). DEP treatment also induced an elevation in the binding of Pol II. In contrast, there was no effect on the intensity of p65 binding to the COX-2 promoter relative to controls (Figure 7 ).
DISCUSSION
A number of studies have shown that the adverse effects of DEP exposure include inflammatory responses that are underlain by an elevated expression of inflammatory mediators (8, 31, 32) . Indeed, it has been demonstrated in vitro and in vivo that DEP can induce expression of proinflammatory genes including cytokines, chemokines, and various mediators in airway alveolar and epithelial cells (31, 32) . Although COX-2 has been associated with several inflammatory diseases (33) , its expression and regulation in human epithelial cells with regard to DEP exposure have not been reported. In this study, we demonstrate for the first time that DEP exposure can induce expression of COX-2 gene at both mRNA and protein levels in bronchial epithelial cells and describe a novel mechanism for this response that involves chromatin modification secondary to a specific degradation of HDAC1.
Given the pivotal role of COX-2 in the synthesis of prostaglandins that are involved in inflammation, our finding that DEP exposure induces its expression is consistent with the adverse effects of DEP inhalation. However, in contrast to the observations presented herein, previous reports showed that DEP exposure had little effect on COX-2 gene expression in human myocytes (9) or murine macrophages and fibroblasts (10) . Furthermore, while DEP exposure was found to enhance LPSstimulated expression of COX-2 gene in human monocytes, it did not show any effect on the modulation of PDGF-and LPSinduced COX-2 expression in murine fibroblasts and macrophages (10) . Cell-type differences may explain the variation in COX-2 induction observed in fibroblasts and macrophages in comparison to airway epithelial cells. The regulation of COX-2 gene expression is subject to oxidative stress, which activates mitogen-activated protein (MAP) kinase cascades, leading to activation of NF-B (34) . It has been demonstrated that DEP can activate NF-B by inducing oxidative stress and activating MAP kinase pathways in both epithelial and macrophage cells (31) . Additional work will be needed to investigate the regulation of COX-2 gene expression, as it differs in these two types of cells in response to DEP. BEAS-2B cells were transfected with plasmid encoding siRNA against HDAC1 and incubated for 48 h. Total RNA was isolated and levels of HDAC1 and COX-2 mRNA were quantified using real-time PCR. Levels of GAPDH were used an internal control. The plasmid encoding scrambled si RNA served as a negative control. (B ) BEAS-2B cells were grown to 70% confluence, and then cells were transfected with COX-2-luciferase reporter plasmid together with plasmid encoding HDAC1 or empty plasmid and incubated for 36 h, followed by treatment with NIST-DEP (10 g/cm 2 ) for 8 h. Plasmid encoding Renilla luciferase was used as an internal control. Luciferase activity was assayed as described in MATERIALS AND METHODS.
The elevation of COX-2 may also have a protective role in response to challenge of DEP. It was reported that COX-2 -/-mice exhibit increased lung inflammation and airway hyperresponsiveness compared with wild type after ovalbumin sensitization and treatment. Gavett and coworkers also reported a similar result using V 2 O 5 (35) . In a study by Bonner and colleagues, the authors showed that ablation of the COX-2 gene in mice leads to increased inflammatory response and development of pulmonary fibrotic lesions after treatment of V 2 O 5 (11) . In this in vitro study we showed that DEP induced expression of COX-2 in human airway epithelial cells. Whether elevated expression of COX-2 in response to DEP plays a protective or detrimental role in airways awaits further study using COX-2 knockout animals. It should be noted that while well-regulated expression of COX-2 has a protective role, prolonged overexpression may be a key player in many human inflammatory disorders.
Post-translational modifications of HDAC have been found to play pivotal roles in the regulation of gene expression. These modifications include phosphorylation (36, 37) , sumoylation (38, Figure 7 . DEP increases binding of p300 to the promoter of COX-2. BEAS-2B cells were treated with NIST-DEP for 4 h. ChIP assay was then performed with anti-Pol II and anti-p300 antibodies. Precipitates from the antibody against IgG served as a negative control. Two percent of the diluted DNA was used as loading control. The lower panel shows schematically the region in the promoter of COX-2 gene, which was amplified by PCR. 39), and ubiquitination (40) . HDACs that are modified with these groups have altered transcriptional repression activity (38, 39) , lose the ability to interact with transcription factors (36), or are targeted for degradation (40) . For example, sumoylation is required for HDAC1 to achieve full repressive activity (39) . Similarly, phosphorylation of HDAC1 and -2 leads to the disruption of its ability to interact with other transcription factors such as YY1 (36) . Some chemicals can selectively target HDAC for proteasome-mediated degradation. Specifically, treatment with quinidine induced degradation of HDAC1 in human breast tumor cell lines (41) . Valproic acid was found to selectively induce degradation of HDAC2, although it did not affect levels of other HDACs, including HDAC1, -3, -4, -5, and -8 (42) . Our present data show that DEP induced selective degradation of HDAC1 via the proteasome-mediated pathways in BEAS-2B cells while having no effect on the protein levels of HDAC2 and HDAC3.
Recently, it has been reported that oxidatively modified proteins can be selectively degraded via the proteasome, through a mechanism that is independent of ubiquitination (43) . The adverse effects that DEP exerts on bronchial epithelial cells has been shown to involve the generation of oxidative stress, which reduces HDAC activity and HDAC2 expression (44) . We therefore speculate that oxidative stress induced by DEP treatment leads to oxidation of HDAC1, which is subsequently recognized by proteasome regulatory components and targeted for degradation. Oxidative stress can also induce ubiquitination of proteins and promote their degradation in this manner (45) . Therefore, further study is needed to distinguish between these two mechanisms as contributors of DEP-induced COX-2 expression.
Although the mechanism responsible for the specificity in mediating the targeted destruction of HDAC1 is not known, selective degradation of HDACs has been observed in inflammatory pulmonary diseases. In bronchial biopsies from patients with asthma, there is a reduction in the expression of HDAC1, while the expression of HDAC2 and HDAC3 are unaffected (30) . In addition, in COPD pulmonary tissue there is a significant reduction in the expression of HDAC2 with lesser reductions in HDAC3 and HDAC5 (46) . Therefore, in view of the fact that the inflammatory response is a central feature in both DEPinduced pathogenesis and lung diseases such as asthma and COPD, it will be of great interest to isolate the components of DEP that induce selective degradation of HDAC1 and to study the mechanisms involved.
The COX-2 promoter contains cis-elements for multiple transcription activators including NF-B, NF-IL-6, AP-1, CRE-binding protein, and C/EBP (47) . Different external stimuli use a combination of distinct cis-elements in the COX-2 gene promoter to activate its expression by activating a specific group of transcription factors (16, 48) . The cis elements used to drive COX-2 gene expression in response to DEP are not yet determined. Nonetheless, DEP has been shown to be a potent activator of NF-B in bronchial epithelial cells (49) . Thus we examined whether DEP increases binding of p65 to COX-2 promoter in this study. Our data demonstrate that p65 is bound to COX-2 in the untreated cells and that its binding is not further increased by stimulation of DEP, which is in contrast to our observation that DEP increased p65 binding to the IL-8 promoter (data not shown). This observation indicates that DEP-induced COX-2 and IL-8 gene expression involves a distinct mechanism at the molecular level. The transcription co-activator p300 and RNA Pol II binding were both increased in the COX-2 promoter in response to DEP treatment. The mechanism through which p300 is recruited to the COX-2 promoter in response to DEP treatment is not known. However, it was reported previously that p300 interacts with p65 (50) . This suggests that DEP induces activation of p300 and promotes its binding to p65 already bound to the COX-2 promoter, leading to the enhanced expression of COX-2 gene. It should be pointed out that we can not exclude the possibility of involvement of other transcription factors in the recruitment of p300 to COX-2 promoter, for example, AP-1, which can be activated by DEP treatment and interact with p300 (42) .
In summary, we provide evidence that DEP exposure can enhance the expression of COX-2 in bronchial epithelial cells at a transcriptional level. We found that the mechanism by which DEP induces COX-2 expression involves chromatin modification. In particular, DEP exposure increases the acetylation of H4, likely by selective degradation of HDAC1 and recruitment of p300. The functional relevance of HDAC1 in the regulation of the COX-2 gene is supported by the evidence that loss of HDAC promotes COX-2 expression, whereas overexpression of HDAC1 inhibits DEP-induced COX-2 transcription. These results expand our understanding of the mechanism of DEP induced inflammatory responses in bronchial epithelial cells. More importantly, the mechanism identified in this study provides a foundation from which we may identify the bioactive components present in DEP and develop strategies to mitigate the adverse effects of DEP inhalation.
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